mgus and thrombotic events: istopmm study results | sæmundur rögnvaldsson, md, phd | ash 2023
Published 8 months ago • 141 plays • Length 4:51Download video MP4
Download video MP3
Similar videos
-
4:27
benefits of early mgus screening: istopmm study results | sæmundur rögnvaldsson, md, phd | ash 2023
-
1:53
istopmm study and early mgus and smm screening | joshua richter, md | ash 2021
-
1:26
istopmm trial - covid vaccine and impact on myeloma | malin hultcrantz, md, phd | ash 2022
-
8:02
screening for monoclonal gammopathy of undetermined significance: first results from istopmm study
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
4:02
ash 2023 | the istopmm study: myeloma screening
-
0:42
istopmm: a new, large & unbiased mgus patient population
-
1:43
an insight into the prevalence of various subtypes of mgus in the istopmm study
-
2:52
how to join the mgus/smoldering myeloma pcrowd study
-
3:11
what is hrsmm? what are the guidelines?
-
3:54
mezigdomide for myeloma | therapies on the horizon
-
2:11
detecting myeloma with single cell sequencing | scott goldsmith, md | ash 2022
-
1:54
the future of multiple myeloma treatment
-
1:26
emerging monoclonal antibodies for the treatment of multiple myeloma
-
1:59
a subgroup analysis of majestec-1: teclistamab in multiple myeloma with high-risk features
-
2:50
how is mgus monitored? should i see a specialist or seek treatment?
-
1:02:06
interpreting mgus/smoldering myeloma labs- what to know and when to take action
-
4:55
genomics | high impact topic (hit)
-
12:38
understanding mgus and smm progression - irene ghobrial, md | mcrt webcast september 26 (2/3)